Lutein and zeaxanthin—Food sources, bioavailability and dietary variety in age-related macular degeneration protection
Lutein and zeaxanthin (L/Z) are the predominant carotenoids which accumulate in the retina
of the eye. The impact of L/Z intake on the risk and progression of age-related macular …
of the eye. The impact of L/Z intake on the risk and progression of age-related macular …
Age‐related macular degeneration: new paradigms for treatment and management of AMD
LF Hernández-Zimbrón… - Oxidative medicine …, 2018 - Wiley Online Library
Age‐related macular degeneration (AMD) is a well‐characterized and extensively studied
disease. It is currently considered the leading cause of visual disability among patients over …
disease. It is currently considered the leading cause of visual disability among patients over …
Assessment of deep generative models for high-resolution synthetic retinal image generation of age-related macular degeneration
Importance Deep learning (DL) used for discriminative tasks in ophthalmology, such as
diagnosing diabetic retinopathy or age-related macular degeneration (AMD), requires large …
diagnosing diabetic retinopathy or age-related macular degeneration (AMD), requires large …
Use of deep learning for detailed severity characterization and estimation of 5-year risk among patients with age-related macular degeneration
PM Burlina, N Joshi, KD Pacheco, DE Freund… - JAMA …, 2018 - jamanetwork.com
Importance Although deep learning (DL) can identify the intermediate or advanced stages of
age-related macular degeneration (AMD) as a binary yes or no, stratified gradings using the …
age-related macular degeneration (AMD) as a binary yes or no, stratified gradings using the …
Hesperetin protects against H2O2-triggered oxidative damage via upregulation of the Keap1-Nrf2/HO-1 signal pathway in ARPE-19 cells
C Zhu, Y Dong, H Liu, H Ren, Z Cui - Biomedicine & Pharmacotherapy, 2017 - Elsevier
Age-related macular degeneration (AMD) is an irreversible vision loss disease that primarily
results from oxidative stress that causes oxidative damage to the retinal pigment epithelial …
results from oxidative stress that causes oxidative damage to the retinal pigment epithelial …
Comparative safety of bevacizumab, ranibizumab, and aflibercept for treatment of neovascular age-related macular degeneration (AMD): a systematic review and …
AA Plyukhova, MV Budzinskaya, KM Starostin… - Journal of clinical …, 2020 - mdpi.com
Background: Since the efficacy of ranibizumab (RBZ), bevacizumab (BVZ) and aflibercept
(AFB) is comparable in neovascular age-related macular degeneration (AMD), we …
(AFB) is comparable in neovascular age-related macular degeneration (AMD), we …
Choriocapillaris changes in dry age-related macular degeneration and geographic atrophy: a review
Age-related macular degeneration (AMD) is a leading cause of central vision loss
worldwide. The progression of dry AMD from early to intermediate stages is primarily …
worldwide. The progression of dry AMD from early to intermediate stages is primarily …
Going non-viral: the Sleeping Beauty transposon system breaks on through to the clinical side
M Hudecek, Z Izsvák, S Johnen, M Renner… - Critical reviews in …, 2017 - Taylor & Francis
Molecular medicine has entered a high-tech age that provides curative treatments of
complex genetic diseases through genetically engineered cellular medicinal products. Their …
complex genetic diseases through genetically engineered cellular medicinal products. Their …
Optical coherence tomography angiography of dry age-related macular degeneration
Optical coherence tomography angiography (OCTA) can be used to visualize alterations in
the choriocapillaris of patients with dry age-related macular degeneration (AMD). These …
the choriocapillaris of patients with dry age-related macular degeneration (AMD). These …
Ranibizumab for exudative age-related macular degeneration: a five year study of adherence to follow-up in a real-life setting
E Boulanger-Scemama, G Querques, F About… - Journal francais d' …, 2015 - Elsevier
Purpose To analyze adherence to follow-up over 5 years in patients treated with intravitreal
ranibizumab for exudative age-related macular degeneration (AMD) in a tertiary health care …
ranibizumab for exudative age-related macular degeneration (AMD) in a tertiary health care …